European Hematology Association - 31st Congress, 2026 (EHA)
11 - 14 June 2026
Etavopivat reduces transfusion requirements in adults and adolescents with transfusion-dependent α- or β-thalassemia: results from the open label phase 2 gladiolus study
Keywords